Request Demo
Last update 21 Aug 2025
GT-719
Last update 21 Aug 2025
Overview
Basic Info
Drug Type TIL therapy |
Synonyms GT-719 |
Target |
Action modulators |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
5
Clinical Trials associated with GT-719NCT07122076
A Single-arm, Open-label Clinical Study of GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases
NCT07132112
A Single-arm, Open-label Clinical Study of GT719 Injection for Moderate to Severe Refractory Autoimmune Disease
NCT06948981
A Single-arm, Open-label, Phase I/II Clinical Study of GT719 Injection for Recurrent/Refractory CD19 Positive Adult B-cell Malignancies
100 Clinical Results associated with GT-719
Login to view more data
100 Translational Medicine associated with GT-719
Login to view more data
100 Patents (Medical) associated with GT-719
Login to view more data
100 Deals associated with GT-719
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute lymphoblastic leukemia recurrent | Phase 2 | China | 25 Sep 2024 | |
| CD19 Expressing Malignancies | Phase 2 | China | 25 Sep 2024 | |
| Refractory acute lymphoid leukemia | Phase 2 | China | 25 Sep 2024 | |
| Scleroderma, Diffuse | Phase 1 | China | 20 Aug 2025 | |
| Idiopathic Inflammatory Myopathies | Phase 1 | China | 01 Aug 2025 | |
| Systemic Lupus Erythematosus | Phase 1 | China | 01 Aug 2025 | |
| Antibody-mediated rejection | Phase 1 | China | 14 Jan 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free